Phathom Pharmaceuticals (PHAT) Times Interest Earned (2022 - 2025)
Phathom Pharmaceuticals (PHAT) has disclosed Times Interest Earned for 4 consecutive years, with -$0.36 as the latest value for Q4 2025.
- On a quarterly basis, Times Interest Earned rose 88.7% to -$0.36 in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.35, a 39.04% increase, with the full-year FY2025 number at -$2.35, up 39.04% from a year prior.
- Times Interest Earned was -$0.36 for Q4 2025 at Phathom Pharmaceuticals, up from -$0.95 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.36 in Q4 2025 to a low of -$13.74 in Q1 2022.
- A 4-year average of -$4.45 and a median of -$3.95 in 2024 define the central range for Times Interest Earned.
- Peak YoY movement for Times Interest Earned: crashed 31.98% in 2024, then soared 88.7% in 2025.
- Phathom Pharmaceuticals' Times Interest Earned stood at -$4.86 in 2022, then fell by 10.41% to -$5.36 in 2023, then surged by 40.41% to -$3.2 in 2024, then skyrocketed by 88.7% to -$0.36 in 2025.
- Per Business Quant, the three most recent readings for PHAT's Times Interest Earned are -$0.36 (Q4 2025), -$0.95 (Q3 2025), and -$3.42 (Q2 2025).